(R)-1-(4-CHLORO-3-FLUOROPHENYL)ETHANE-1,2-DIOL, 95.0%, 100mg

Oxalic acid dihydrate, min. 99%, cryst., 5 kg, plastic packaging.

N-(2,5-dichlorobenzoyl)glycine, 95.0%, 10g

Ethyl 3-(2,6-Dichloro-5-fluoro-3-pyridyl)-3-oxopropionate>98.0%(T)25g

(2-Chloro-4-formylphenyl)boronic acid, 95.0%, 100mg

Ethyl 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepine-2-carboxylate;hydrochloride, 98+%, 100mg

2-[2-Chloro-4-(trifluoromethyl)phenyl]-1,3-dioxolane, 98%, 1g

5-Chloro-2,4-dihydroxybenzaldehyde, 97.0%, 1g

N,N'-Bis(2,4,6-trimethoxyphenyl)oxalamide, 97%, 250mg

17-(tert-Butoxy)-17-oxoheptadecanoic acid, 97%, 100mg

4-(4-piperidinyl)-2(1H)-pyridinone dihydrochloride, 95.0%, 5g

Methyl 4-bromo-2-(methylsulfonyl)benzoate, 95.0%, 1g

5,6,7,8-Tetrahydro-1,6-naphthyridin-2(1H)-one, 95.0%, 5g